JAZZ
Jazz Pharmaceuticals (JAZZ)
$32
About Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Details
Daily high
$231.40
Daily low
$228.37
Price at open
$230.55
52 Week High
$243.32
52 Week Low
$105.00
Market cap
14.5B
Dividend yield
0.00%
Volume
34,176
Avg. volume
911,728
P/E ratio
-12,530.43
Jazz Pharmaceuticals News
Details
Daily high
$231.40
Daily low
$228.37
Price at open
$230.55
52 Week High
$243.32
52 Week Low
$105.00
Market cap
14.5B
Dividend yield
0.00%
Volume
34,176
Avg. volume
911,728
P/E ratio
-12,530.43